Trial intelligence / Profile preview

Chronic Pain Treatment with Human Mesenchymal Stem Cell Conditioned Medium

jRCT1051230174Recruiting

Sponsor
Nagamine Medical Clinic Ginza
Start
Jan 2024
Countries
1
01

Overview

Open-label, single-arm trial in chronic pain, sponsored by Nagamine Medical Clinic Ginza. Primary endpoints: Effect of pain on daily life, Pain pattern and 5 more. Started Jan 2024; status: recruiting.

02

Conditions

chronic pain

Beyond the preview

Go deeper on jRCT1051230174.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1051230174.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call